TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmbiotech Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
19,134
|
429
|
0 |
Financial expenses |
137
|
0 | |
Earnings before taxes |
5,396
|
1,717
|
-48 |
Total assets |
7,280
|
23,833
|
22,961 |
Current assets |
3,521
|
3,590
|
18,964 |
Current liabilities |
19
|
18,508
|
19,069 |
Equity capital |
77
|
155
|
86 |
- share capital |
29
|
27
|
29 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
1.1%
|
0.7%
|
0.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
28.2%
|
400.2% | |
Return on assets (ROA) |
7.8%
|
-0.2% | |
Current ratio |
18531.6%
|
19.4%
|
99.4% |
Return on equity (ROE) |
7007.8%
|
1107.7%
|
-55.8% |
Change turnover |
18,684
|
429 | |
Change turnover % | 4155% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.